COVID‐19 (severe acute respiratory syndrome coronavirus 2 [SARS‐CoV‐2]) is associated
with coagulopathy through numerous mechanisms. The reported incidence of venous …

AIMS OF THE STUDY Many centres have noticed a high number of venous
thromboembolism (VTE) events among critically ill inpatients with COVID-19 pneumonia …

Background: Early during the course of the ongoing COVID-19 pandemic, reports suggested
alarmingly high incidences for thromboembolic events in critically ill patients with COVID-19 …

Background COVID-19 related in-hospital venous thromboembolism (VTE) incidence is high
but data reported vary significantly. Some studies show that up to half of the events are …

Abstract Coronavirus disease (COVID-19) is caused by the novel severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) and is responsible for the ongoing 2019–2020 …

Abstract Purpose of Review Novel coronavirus disease 2019 (COVID-19) has been
associated with an increased risk of arterial and venous thromboembolic (VTE) diseases …

Although COVID-19 has been reported to be associated with high rates of venous
thromboembolism (VTE), the risk of VTE and bleeding after hospitalization for COVID-19 …

Background Thrombosis and pulmonary embolism appear to be major causes of mortality in
hospitalized coronavirus disease 2019 (COVID-19) patients. However, few studies have …

Background Since the beginning of the coronavirus disease 2019 (COVID-19) pandemic,
the incidence of thromboembolism has been increasingly reported. The aim of this …

Background Patients with COVID-19 infection are commonly reported to have an increased
risk of venous thrombosis. The choice of anti-thrombotic agents and doses are currently …